Invitrogen Forms Integration Team, Expects $60M in Synergies in 2009 | GenomeWeb
NEW YORK (GenomeWeb News) – Invitrogen announced today that it has named Mark Smedley, the firm’s global head of operations, to lead the integration team for its $6.7 billion acquisition of Applied Biosystems.
 
The Carlsbad, Calif.-based firm also said that it expects to realize synergies of $60 million in 2009 and total cost and revenue synergies of $175 million by 2011 as a result of the acquisition.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.